InsiderClue
Insiders · Profile

EPIQ Capital Group, LLC

IA/Managing Member of 10% Owne at Quince Therapeutics. Filing since 10 May 2019. CIK 0001779453

Company
Date
Role
Action
Shares
Amount
Of holding
QNCX Quince Therapeutics, Inc.
12 Jun 2020
IA/Managing Member of 10% Owne
Bought
2,440
$107.51K
0.1%
QNCX Quince Therapeutics, Inc.
11 Jun 2020
IA/Managing Member of 10% Owne
Bought
6,600
$292.51K
0.2%
QNCX Quince Therapeutics, Inc.
22 May 2020
IA/Managing Member of 10% Owne
Bought
2,085
$116.55K
0.1%
QNCX Quince Therapeutics, Inc.
21 May 2020
IA/Managing Member of 10% Owne
Bought
520
$29.02K
0.0%
QNCX Quince Therapeutics, Inc.
20 May 2020
IA/Managing Member of 10% Owne
Bought
6,085
$352.60K
0.2%
QNCX Quince Therapeutics, Inc.
21 Aug 2019
IA/Managing Member 10% owner
Bought
1,635
$40.66K
0.1%
QNCX Quince Therapeutics, Inc.
21 Aug 2019
IA/Managing Member 10% owner
Bought
420
$10.44K
0.0%
QNCX Quince Therapeutics, Inc.
20 Aug 2019
IA/Managing Member 10% owner
Bought
2,310
$59.34K
0.1%
QNCX Quince Therapeutics, Inc.
20 Aug 2019
IA/Managing Member 10% owner
Bought
600
$15.41K
0.0%
QNCX Quince Therapeutics, Inc.
19 Aug 2019
IA/Managing Member 10% owner
Bought
2,100
$55.64K
0.1%
QNCX Quince Therapeutics, Inc.
16 Aug 2019
IA/Managing Member 10% owner
Bought
700
$18.46K
0.0%
QNCX Quince Therapeutics, Inc.
10 May 2019
IA/Managing Member 10% owner
Bought
4,170
$115.01K
0.1%
QNCX Quince Therapeutics, Inc.
10 May 2019
IA/Managing Member 10% owner
Bought
4,350
$114.88K
0.2%
QNCX Quince Therapeutics, Inc.
10 May 2019
IA/Managing Member 10% owner
Bought
80
$2.16K
0.0%
14 decisions on file.